-
1
-
-
0015642617
-
Phase II evaluation of adriamycin in human neoplasia
-
O'Bryan RM, Luce JK, Talley RW, Gottlieb JA, Baker LH, Bonadonna G: Phase II evaluation of adriamycin in human neoplasia. Cancer 32: 11-18, 1973
-
(1973)
Cancer
, vol.32
, pp. 11-18
-
-
O'Bryan, R.M.1
Luce, J.K.2
Talley, R.W.3
Gottlieb, J.A.4
Baker, L.H.5
Bonadonna, G.6
-
2
-
-
0017704418
-
Dose response evaluation of adriamycin in human neoplasia
-
O'Bryan RM, Baker LH, Gottlieb JE, Rivkin SE, Balcerzak SP, Grumet GW, Salmon SE, Moon TE, Hoogstraten B: Dose response evaluation of adriamycin in human neoplasia. Cancer 39: 1940-1948, 1977
-
(1977)
Cancer
, vol.39
, pp. 1940-1948
-
-
O'Bryan, R.M.1
Baker, L.H.2
Gottlieb, J.E.3
Rivkin, S.E.4
Balcerzak, S.P.5
Grumet, G.W.6
Salmon, S.E.7
Moon, T.E.8
Hoogstraten, B.9
-
3
-
-
0015987706
-
Adriamycin chemotherapy - Efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
-
Benjamin RS, Wiernik PH, Bachur NR: Adriamycin chemotherapy - efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 33: 19-27, 1974
-
(1974)
Cancer
, vol.33
, pp. 19-27
-
-
Benjamin, R.S.1
Wiernik, P.H.2
Bachur, N.R.3
-
4
-
-
0020354811
-
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
-
Schoenfeld DA, Rosenbaum C, Horton J, Wolter JW, Falkson G, DeConti RC: A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer 50: 2757-2762, 1982
-
(1982)
Cancer
, vol.50
, pp. 2757-2762
-
-
Schoenfeld, D.A.1
Rosenbaum, C.2
Horton, J.3
Wolter, J.W.4
Falkson, G.5
DeConti, R.C.6
-
5
-
-
0025150176
-
Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas
-
Borden EC, Amato DA, Edmonson JK, Ritch PS, Shiraki M: Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer 66: 862-867, 1990
-
(1990)
Cancer
, vol.66
, pp. 862-867
-
-
Borden, E.C.1
Amato, D.A.2
Edmonson, J.K.3
Ritch, P.S.4
Shiraki, M.5
-
6
-
-
0027256397
-
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas
-
Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11: 1269-1275, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 1269-1275
-
-
Edmonson, J.H.1
Ryan, L.M.2
Blum, R.H.3
Brooks, J.S.4
Shiraki, M.5
Frytak, S.6
Parkinson, D.R.7
-
7
-
-
0023176119
-
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas
-
Borden EC, Amato DA, Rosenbaum C, Enterline HT, Shiraki MJ, Creech RH, Lerner HJ, Carbone PP: Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol 5: 840-850, 1987
-
(1987)
J Clin Oncol
, vol.5
, pp. 840-850
-
-
Borden, E.C.1
Amato, D.A.2
Rosenbaum, C.3
Enterline, H.T.4
Shiraki, M.J.5
Creech, R.H.6
Lerner, H.J.7
Carbone, P.P.8
-
8
-
-
0023235065
-
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: A randomized comparative trial
-
A phase III, Southwest Oncology Group Study (7613)
-
Baker LH, Frank J, Fine G, Balcerzalk SP, Stephens RL, Stuckey WJ, Rivkin S, Saiki J, Ward JH: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). J Clin Oncol 5: 851-861, 1987
-
(1987)
J Clin Oncol
, vol.5
, pp. 851-861
-
-
Baker, L.H.1
Frank, J.2
Fine, G.3
Balcerzalk, S.P.4
Stephens, R.L.5
Stuckey, W.J.6
Rivkin, S.7
Saiki, J.8
Ward, J.H.9
-
9
-
-
0026487406
-
Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas
-
Mason M, Robinson W, Harmer C, Westbury G: Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas. Clin Oncol (R Coll Radiol) 4: 32-35, 1992
-
(1992)
Clin Oncol (R Coll Radiol)
, vol.4
, pp. 32-35
-
-
Mason, M.1
Robinson, W.2
Harmer, C.3
Westbury, G.4
-
10
-
-
0018145150
-
Comparison of regional versus systemic chemotherapy with adriamycin
-
Didolkar MS, Kanter PW, Baffi RR, Schwartz HS, Lopez R: Comparison of regional versus systemic chemotherapy with adriamycin. Ann Surg 187: 332-336, 1978
-
(1978)
Ann Surg
, vol.187
, pp. 332-336
-
-
Didolkar, M.S.1
Kanter, P.W.2
Baffi, R.R.3
Schwartz, H.S.4
Lopez, R.5
-
11
-
-
0027162899
-
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs
-
Gabizon AA, Barenholz Y, Bialer M: Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 10: 703-708, 1993
-
(1993)
Pharm Res
, vol.10
, pp. 703-708
-
-
Gabizon, A.A.1
Barenholz, Y.2
Bialer, M.3
-
12
-
-
0028349925
-
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes
-
Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenhoiz Y: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 987-992
-
-
Gabizon, A.1
Catane, R.2
Uziely, B.3
Kaufman, B.4
Safra, T.5
Cohen, R.6
Martin, F.7
Huang, A.8
Barenhoiz, Y.9
-
13
-
-
0030024958
-
Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma
-
Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD: Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36: 55-63, 1996
-
(1996)
J Clin Pharmacol
, vol.36
, pp. 55-63
-
-
Northfelt, D.W.1
Martin, F.J.2
Working, P.3
Volberding, P.A.4
Russell, J.5
Newman, M.6
Amantea, M.A.7
Kaplan, L.D.8
-
14
-
-
0025731906
-
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
-
Alien TM, Hansen C, Martin F, Redemann C, Yau-Young A: Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066: 29-36, 1991
-
(1991)
Biochim Biophys Acta
, vol.1066
, pp. 29-36
-
-
Alien, T.M.1
Hansen, C.2
Martin, F.3
Redemann, C.4
Yau-Young, A.5
-
16
-
-
0025740783
-
Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes
-
Oudard S, Thierry A, Jorgensen TJ, Rahman A: Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes. Cancer Chemother Pharmacol 28: 259-265, 1991
-
(1991)
Cancer Chemother Pharmacol
, vol.28
, pp. 259-265
-
-
Oudard, S.1
Thierry, A.2
Jorgensen, T.J.3
Rahman, A.4
-
17
-
-
0026808970
-
Effect of liposomes on P-glycoprotein function in multidrug resistant cells
-
Thierry AR, Dritschilo A, Rahman A: Effect of liposomes on P-glycoprotein function in multidrug resistant cells. Biochem Biophys Res Commun 187: 1098-1105, 1992
-
(1992)
Biochem Biophys Res Commun
, vol.187
, pp. 1098-1105
-
-
Thierry, A.R.1
Dritschilo, A.2
Rahman, A.3
-
18
-
-
0031822413
-
The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin
-
Berry G, Billingham M, Alderman E, Richardson P, Torti F, Lum B, Patek A, Martin FJ: The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. Ann Oncol 9:711-716, 1998
-
(1998)
Ann Oncol
, vol.9
, pp. 711-716
-
-
Berry, G.1
Billingham, M.2
Alderman, E.3
Richardson, P.4
Torti, F.5
Lum, B.6
Patek, A.7
Martin, F.J.8
-
19
-
-
0024461340
-
Ifosfamide plus doxorubicin in metastatic adult sarcomas: A multiinstitutional phase II trial
-
Loehrer PJ Sr, Sledge GW Jr, Nicaise C, Usakewicz J, Hainsworth JW, Martelo OJ, Omura G, Braun TJ: Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multiinstitutional phase II trial. J Clin Oncol 7: 1655-1659, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 1655-1659
-
-
Loehrer P.J., Sr.1
Sledge G.W., Jr.2
Nicaise, C.3
Usakewicz, J.4
Hainsworth, J.W.5
Martelo, O.J.6
Omura, G.7
Braun, T.J.8
-
20
-
-
0031861021
-
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
-
Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16: 2445-2451, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 2445-2451
-
-
Northfelt, D.W.1
Dezube, B.J.2
Thommes, J.A.3
Miller, B.J.4
Fischl, M.A.5
Friedman-Kien, A.6
Kaplan, L.D.7
Du Mond, C.8
Mamelok, R.D.9
Henry, D.H.10
-
21
-
-
0029038996
-
Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies
-
Uziely B, Jeffers S, Isacson R, Kutsch K, Wei-Tsao D, Yehoshua Z, Libson E, Muggia FM, Gabizon A: Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 13: 1777-1785, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 1777-1785
-
-
Uziely, B.1
Jeffers, S.2
Isacson, R.3
Kutsch, K.4
Wei-Tsao, D.5
Yehoshua, Z.6
Libson, E.7
Muggia, F.M.8
Gabizon, A.9
-
22
-
-
0031941991
-
Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
-
International Pegylated Liposomal Doxorubicin Study Group
-
Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ: Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group, J Clin Oncol 16: 683-691, 1998
-
(1998)
J Clin Oncol
, vol.16
, pp. 683-691
-
-
Stewart, S.1
Jablonowski, H.2
Goebel, F.D.3
Arasteh, K.4
Spittle, M.5
Rios, A.6
Aboulafia, D.7
Galleshaw, J.8
Dezube, B.J.9
-
23
-
-
0030959798
-
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial
-
Ranson MR, Carmichael J, O'Byrne K, Stewart S, Smith D, Howell A: Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial [see comments]. J Clin Oncol 15: 3185-3191, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 3185-3191
-
-
Ranson, M.R.1
Carmichael, J.2
O'Byrne, K.3
Stewart, S.4
Smith, D.5
Howell, A.6
-
24
-
-
0031055830
-
Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
-
Muggia FM, Hainsworth JD, Jeffers S, Miller R, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang LJ: Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol 15: 987-993, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 987-993
-
-
Muggia, F.M.1
Hainsworth, J.D.2
Jeffers, S.3
Miller, R.4
Groshen, S.5
Tan, M.6
Roman, L.7
Uziely, B.8
Muderspach, L.9
Garcia, A.10
Burnett, A.11
Greco, F.A.12
Morrow, C.P.13
Paradiso, L.J.14
Liang, L.J.15
-
25
-
-
0031795043
-
A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
-
Garcia AA, Kempf RA, Rogers M, Muggia FM: A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas. Ann Oncol 9: 1131-1133, 1998
-
(1998)
Ann Oncol
, vol.9
, pp. 1131-1133
-
-
Garcia, A.A.1
Kempf, R.A.2
Rogers, M.3
Muggia, F.M.4
-
26
-
-
0013170748
-
A phase II trial of pegylated liposomal doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer
-
abstract 2090
-
Skubitz K: A phase II trial of pegylated liposomal doxorubicin (Doxil) demonstrates activity in refractory sarcoma, mesothelioma, and head and neck cancer. Proc Am Soc Clin Oncol 18: 541a (abstract 2090), 1999
-
(1999)
Proc am Soc Clin Oncol
, vol.18
-
-
Skubitz, K.1
-
27
-
-
0005755484
-
Liposomal doxorubicin (CAELYX) in advanced pretreated soft tissue sarcomas (STS): A phase II trial of the Italian sarcoma group (ISG)
-
abstract 2087
-
Toma S, Tucci A, Villani G, Carteni G, Palumbo R: Liposomal doxorubicin (CAELYX) in advanced pretreated soft tissue sarcomas (STS): a phase II trial of the Italian sarcoma group (ISG). Proc Am Soc Clin Oncol 18: 540a (abstract 2087), 1999
-
(1999)
Proc am Soc Clin Oncol
, vol.18
-
-
Toma, S.1
Tucci, A.2
Villani, G.3
Carteni, G.4
Palumbo, R.5
-
28
-
-
0004845305
-
A randomized Phase II trial of Caelyx/Doxil versus doxorubicin in advanced or metastatic soft tissue sarcomas (STS) - An EORTC soft tissue and bone sarcoma group (STBS) trial
-
(abstract 2089)
-
Judson I, Radford J, Blay J-Y, Van hoesel W, LeCesne A, van Oosterom A, Nielsen O, Camb C, Wall R, Harris M, Hermes C, Donate Di Paola E, Verweij J: A randomized Phase II trial of Caelyx/Doxil versus doxorubicin in advanced or metastatic soft tissue sarcomas (STS) - an EORTC soft tissue and bone sarcoma group (STBS) trial. Proc Am Soc Clin Oncol 18: 541a (abstract 2089), 1999
-
(1999)
Proc am Soc Clin Oncol
, vol.18
-
-
Judson, I.1
Radford, J.2
Blay, J.-Y.3
Van Hoesel, W.4
LeCesne, A.5
Van Oosterom, A.6
Nielsen, O.7
Camb, C.8
Wall, R.9
Harris, M.10
Hermes, C.11
Donate Di Paola, E.12
Verweij, J.13
-
29
-
-
0030994523
-
Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma
-
Casper ES, Schwartz GK, Sugarman A, Leung D, Brennan MF: Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma. J Clin Oncol 15: 2111-2117, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 2111-2117
-
-
Casper, E.S.1
Schwartz, G.K.2
Sugarman, A.3
Leung, D.4
Brennan, M.F.5
|